Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2502549rdf:typepubmed:Citationlld:pubmed
pubmed-article:2502549lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:2502549lifeskim:mentionsumls-concept:C0282549lld:lifeskim
pubmed-article:2502549lifeskim:mentionsumls-concept:C0003693lld:lifeskim
pubmed-article:2502549lifeskim:mentionsumls-concept:C0205615lld:lifeskim
pubmed-article:2502549lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:2502549lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:2502549lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:2502549lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:2502549pubmed:issue22lld:pubmed
pubmed-article:2502549pubmed:dateCreated1989-9-7lld:pubmed
pubmed-article:2502549pubmed:abstractTextExposure of human HL60 cells to dimethyl sulfoxide results in their differentiation to mature granulocyte-like cells that concomitantly acquire the capacity to synthesize leukotrienes. The appearance of 5-lipoxygenase mRNA during differentiation indicated that these cells provide a useful model system for the biosynthesis and regulation of 5-lipoxygenase. Immunoblot analysis of protein from differentiated HL60 cells detected a 78,000-Da species comigrating with 5-lipoxygenase purified from human peripheral blood leukocytes. Metabolic labeling studies indicated that both undifferentiated and differentiated HL60 cells synthesized 5-lipoxygenase; however, the differentiated cells incorporated approximately 4.4-fold more [35S]methionine into 5-lipoxygenase protein than did controls. In addition, the differentiated HL60 cells contained approximately 3.3-fold more 5-lipoxygenase enzyme activity than undifferentiated cells. Metabolic labeling studies failed to demonstrate any post-translational modifications of 5-lipoxygenase, including proteolysis, mannose glycosylation, myristic acid acylation, or phosphorylation. When differentiated HL60 cells were incubated with [35S]methionine for 4 versus 16 h, no difference was observed in the pattern of total radiolabeled supernatant protein; however, there was a significant increase in the incorporation of radioactivity into immunoprecipitable 5-lipoxygenase protein from cells labeled for 16 as compared with 4 h. Pulse-chase studies demonstrated that the t1/2 of 5-lipoxygenase in these cells is approximately 26 h. Activation of differentiated HL60 cells with Ca2+ ionophore A23187 resulted in the loss of 5-lipoxygenase protein and activity from the cytosol and the accumulation of inactive protein in a membrane fraction. Following ionophore stimulation, no augmentation in the rate of 5-lipoxygenase synthesis occurred in order to compensate for the loss of the translocated/inactive enzyme. Finally, additional 5-lipoxygenase was able to translocate to the membrane in response to subsequent ionophore challenges.lld:pubmed
pubmed-article:2502549pubmed:languageenglld:pubmed
pubmed-article:2502549pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2502549pubmed:citationSubsetIMlld:pubmed
pubmed-article:2502549pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2502549pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2502549pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2502549pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2502549pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2502549pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2502549pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2502549pubmed:statusMEDLINElld:pubmed
pubmed-article:2502549pubmed:monthAuglld:pubmed
pubmed-article:2502549pubmed:issn0021-9258lld:pubmed
pubmed-article:2502549pubmed:authorpubmed-author:RouzerC ACAlld:pubmed
pubmed-article:2502549pubmed:authorpubmed-author:KargmanSSlld:pubmed
pubmed-article:2502549pubmed:issnTypePrintlld:pubmed
pubmed-article:2502549pubmed:day5lld:pubmed
pubmed-article:2502549pubmed:volume264lld:pubmed
pubmed-article:2502549pubmed:ownerNLMlld:pubmed
pubmed-article:2502549pubmed:authorsCompleteYlld:pubmed
pubmed-article:2502549pubmed:pagination13313-20lld:pubmed
pubmed-article:2502549pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:meshHeadingpubmed-meshheading:2502549-...lld:pubmed
pubmed-article:2502549pubmed:year1989lld:pubmed
pubmed-article:2502549pubmed:articleTitleStudies on the regulation, biosynthesis, and activation of 5-lipoxygenase in differentiated HL60 cells.lld:pubmed
pubmed-article:2502549pubmed:affiliationMerck Frosst Canada Inc., Pointe Claire-Dorval, Quebec, Canada.lld:pubmed
pubmed-article:2502549pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2502549lld:pubmed